Catalyst Wire Dossier Catalyst Wire Dossier

FFX

· Cornerstone Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FFX, covering 2023-01-03 to 2023-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas [Phase 3]

See pricing